Norges Bank’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Norges Bank’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,374,538	Closed	-$25.6M	–	2216
2022 Q1	$25.6M	Buy	1,374,538 +205,847	+18%	+$3.7M	0.01%	1257
2021 Q4	$25M	Buy	1,168,691 +293,458	+34%	+$5.78M	0.01%	1351
2021 Q3	$16.2M	Buy	875,233 +309,760	+55%	+$6.24M	﹤0.01%	1594
2021 Q2	$12.1M	Sell	565,473 -45,523	-7%	-$926K	﹤0.01%	1720
2021 Q1	$11.8M	Buy	+610,996	New	+$10.8M	﹤0.01%	1742

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Norges Bank's OCDX Position: Q2 2022 in Review

Norges Bank sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 1,374,538 shares — an estimated $25.6M sold.

Norges Bank first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $25.6M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Norges Bank reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Norges Bank sold 1,374,538 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $25.6M.
Norges Bank first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Norges Bank's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $25.6M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Norges Bank's 13F filing for Q2 2022, filed 11 Aug 2022.